New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention Options By Marc-André LeBlanc, Founding member of IRMA
International Rectal Microbicide Advocates (IRMA) and our many partners and allies believe we need an array of HIV prevention options. There has been enormous progress in the field of HIV prevention research in recent years. The remarkably high efficacy of antiretroviral drugs (ARVs) for prevention has been demonstrated, both for oral pre-exposure prophylaxis ( PrEP, now approved and subsidized in several countries ) and through treatment leading to viral suppression or “undetectability” ( U=U, Undetectable = Untransmittable ).
Microbicide—products that could be used vaginally or rectally to reduce a … Lire la suite